{"id":{"repo_id":"vilnius","oai_identifier":"oai:vu.lt:elaba:193303003"},"canonical_url":"https://search.ndltd.org/etd/vilnius/oai:vu.lt:elaba:193303003","repository":{"repo_id":"vilnius","name":"Vilnius University","base_url":"https://epublications.vu.lt/oai"},"display":{"title":"DNR metilinimo ir miRNR žymenų paieška įvairaus tipo diabetu sergančių asmenų skystosios biopsijos mėginiuose /","abstract":"Aim of the research: to evaluate potential DNA methylation, gene expression and miRNA biomarkers in liquid biopsy samples of patients with various types of diabetes. Conclusions: 1. HIF3A and KLF14 gene promoters were methylated in 5,5% and 10% blood samples, respectively, taken during 24-28 pregnancy week from women diagnosed with gestational diabetes. HIF3A, KLF14, NAALAD2, SLC2A4 gene methylation was found in 25%, 30%, 10% ir 25% blood samples, respectively, taken 6-12 weeks after giving birth. DNA methylation was not found in urine samples. 2. SOX2 and STAT3 transcripts were detected in whole blood from type 1 and type 2 diabetes patients with various complications, but not in plasma samples, therefore studied genes are not potential prognostic biomarkers to monitor diabetes progress. 3. The difference between miR-16-5p, miR-27a-3p, miR-152-3p and miR-155-5p quantity found in samples from type 1 and type 2 diabetes patients with various complications was significant (p < 0,001); MiR-16-5p was associated with development of autoimmune diseases. Following miRNAs were not associated with any diabetes complications (p > 0,050). 4. No significant correlation was found between studied miRNAs in plasma samples and type 1 or type 2 diabetes. However, miR-27a-3p and miR-152-3p correlated with duration of disease and miR-16-5p showed a negative correlation with a patient‘s height (p = 0,028).","abstract_html":"Aim of the research: to evaluate potential DNA methylation, gene expression and miRNA biomarkers in liquid biopsy samples of patients with various types of diabetes. Conclusions: 1. HIF3A and KLF14 gene promoters were methylated in 5,5% and 10% blood samples, respectively, taken during 24-28 pregnancy week from women diagnosed with gestational diabetes. HIF3A, KLF14, NAALAD2, SLC2A4 gene methylation was found in 25%, 30%, 10% ir 25% blood samples, respectively, taken 6-12 weeks after giving birth. DNA methylation was not found in urine samples. 2. SOX2 and STAT3 transcripts were detected in whole blood from type 1 and type 2 diabetes patients with various complications, but not in plasma samples, therefore studied genes are not potential prognostic biomarkers to monitor diabetes progress. 3. The difference between miR-16-5p, miR-27a-3p, miR-152-3p and miR-155-5p quantity found in samples from type 1 and type 2 diabetes patients with various complications was significant (p &lt; 0,001); MiR-16-5p was associated with development of autoimmune diseases. Following miRNAs were not associated with any diabetes complications (p &gt; 0,050). 4. No significant correlation was found between studied miRNAs in plasma samples and type 1 or type 2 diabetes. However, miR-27a-3p and miR-152-3p correlated with duration of disease and miR-16-5p showed a negative correlation with a patient‘s height (p = 0,028).","abstract_has_math":false,"creators":["Liulaitytė, Dovilė,"],"institution":"Institutional Repository of Vilnius University","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020","date_published":"2020","updated_at":"2026-11-19T09:57:07Z","subjects":[],"languages":["lit"],"rights":["info:eu-repo/semantics/openAccess"],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://repository.vu.lt/VU:ELABAETD193303003&prefLang=en_US","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://repository.vu.lt/VU:ELABAETD193303003&prefLang=en_US","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":"open","embargo_until":null,"access_note":null},"source_record":{"url":"https://epublications.vu.lt/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Avu.lt%3Aelaba%3A193303003","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Liulaitytė, Dovilė,"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020"]},{"key":"dc:publisher","label":"Institution","values":["Institutional Repository of Vilnius University"]},{"key":"dc:relation","label":"Dc Relation","values":["https://epublications.vu.lt/object/elaba:193303003/193303003.pdf"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/bachelorThesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["lit"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://repository.vu.lt/VU:ELABAETD193303003&prefLang=en_US"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Aim of the research: to evaluate potential DNA methylation, gene expression and miRNA biomarkers in liquid biopsy samples of patients with various types of diabetes. Conclusions: 1. HIF3A and KLF14 gene promoters were methylated in 5,5% and 10% blood samples, respectively, taken during 24-28 pregnancy week from women diagnosed with gestational diabetes. HIF3A, KLF14, NAALAD2, SLC2A4 gene methylation was found in 25%, 30%, 10% ir 25% blood samples, respectively, taken 6-12 weeks after giving birth. DNA methylation was not found in urine samples. 2. SOX2 and STAT3 transcripts were detected in whole blood from type 1 and type 2 diabetes patients with various complications, but not in plasma samples, therefore studied genes are not potential prognostic biomarkers to monitor diabetes progress. 3. The difference between miR-16-5p, miR-27a-3p, miR-152-3p and miR-155-5p quantity found in samples from type 1 and type 2 diabetes patients with various complications was significant (p < 0,001); MiR-16-5p was associated with development of autoimmune diseases. Following miRNAs were not associated with any diabetes complications (p > 0,050). 4. No significant correlation was found between studied miRNAs in plasma samples and type 1 or type 2 diabetes. However, miR-27a-3p and miR-152-3p correlated with duration of disease and miR-16-5p showed a negative correlation with a patient‘s height (p = 0,028)."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["DNR metilinimo ir miRNR žymenų paieška įvairaus tipo diabetu sergančių asmenų skystosios biopsijos mėginiuose /","Analysis of dna methylation and mirna biomarkers in liquid-biopsy samples of patients with various types of diabetes mellitus."]}]}],"canonical_facts":{"dc:creator":["Liulaitytė, Dovilė,"],"dc:date":["2020"],"dc:description":["Aim of the research: to evaluate potential DNA methylation, gene expression and miRNA biomarkers in liquid biopsy samples of patients with various types of diabetes. Conclusions: 1. HIF3A and KLF14 gene promoters were methylated in 5,5% and 10% blood samples, respectively, taken during 24-28 pregnancy week from women diagnosed with gestational diabetes. HIF3A, KLF14, NAALAD2, SLC2A4 gene methylation was found in 25%, 30%, 10% ir 25% blood samples, respectively, taken 6-12 weeks after giving birth. DNA methylation was not found in urine samples. 2. SOX2 and STAT3 transcripts were detected in whole blood from type 1 and type 2 diabetes patients with various complications, but not in plasma samples, therefore studied genes are not potential prognostic biomarkers to monitor diabetes progress. 3. The difference between miR-16-5p, miR-27a-3p, miR-152-3p and miR-155-5p quantity found in samples from type 1 and type 2 diabetes patients with various complications was significant (p < 0,001); MiR-16-5p was associated with development of autoimmune diseases. Following miRNAs were not associated with any diabetes complications (p > 0,050). 4. No significant correlation was found between studied miRNAs in plasma samples and type 1 or type 2 diabetes. However, miR-27a-3p and miR-152-3p correlated with duration of disease and miR-16-5p showed a negative correlation with a patient‘s height (p = 0,028)."],"dc:format":["application/pdf"],"dc:identifier":["https://repository.vu.lt/VU:ELABAETD193303003&prefLang=en_US"],"dc:language":["lit"],"dc:publisher":["Institutional Repository of Vilnius University"],"dc:relation":["https://epublications.vu.lt/object/elaba:193303003/193303003.pdf"],"dc:rights":["info:eu-repo/semantics/openAccess"],"dc:title":["DNR metilinimo ir miRNR žymenų paieška įvairaus tipo diabetu sergančių asmenų skystosios biopsijos mėginiuose /","Analysis of dna methylation and mirna biomarkers in liquid-biopsy samples of patients with various types of diabetes mellitus."],"dc:type":["info:eu-repo/semantics/bachelorThesis"]},"updated_at":"2026-11-19T09:57:07Z"}